News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Will Verastem (VSTM) Make You Vera-Rich?



9/13/2017 5:58:32 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
If you follow Verastem (NASDAQ:VSTM), you probably know that they've had a very good 2017, going from $1.14 to open the year up to $5.40 as of me writing this. An article by Jonathan Faison called Verastem Outlook Post Duo Results does an excellent job explaining VSTM's phase 3 trial data for Duvelisib (DUO for short), so I won't rehash that. What I've been thinking about recently is trying to get some sort of valuation for VSTM.

Read at Seeking Alpha


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES